Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.88
0.10 (12.81%)
At close: Aug 15, 2025, 3:59 PM
0.88
0.02%
After-hours: Aug 15, 2025, 04:52 PM EDT

Sutro Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-227.46M -106.79M -119.2M -105.54M
Depreciation & Amortization
7.22M 6.82M 5.69M 4.84M
Stock-Based Compensation
24.69M 24.91M 26.3M 23.24M
Other Working Capital
-19.27M -10.23M 100.29M -12.61M
Other Non-Cash Items
-4.88M -2.17M -13.65M 6.16M
Deferred Income Tax
n/a n/a n/a 7.24M
Change in Working Capital
8.9M -34.38M 104.41M -17.62M
Operating Cash Flow
-191.54M -111.62M 3.55M -81.68M
Capital Expenditures
-3.1M -4.32M -7.86M -15.32M
Cash Acquisitions
n/a n/a 28.74M n/a
Purchase of Investments
-461.52M -460.3M -216.67M -248.73M
Sales Maturities Of Investments
683.13M 460.69M 189.5M 166.73M
Other Investing Acitivies
n/a n/a -28.73M 9K
Investing Cash Flow
218.51M -3.92M -35.02M -97.31M
Debt Repayment
-4.08M -12.5M -9.38M n/a
Common Stock Repurchased
n/a n/a n/a -7K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.61M 138.08M 1.42M 4.25M
Financial Cash Flow
94.05M 137.55M 48.31M 3.26M
Net Cash Flow
121.02M 22.01M 16.84M -175.74M
Free Cash Flow
-194.64M -115.93M -4.31M -97M